Terry Grimm 

Terry Grimm graduated with a bachelor’s degree in nuclear engineering from Purdue. He later earned a PhD in nuclear engineering and plasma physics from the Massachusetts Institute of Technology, Afterward, Grimm worked as a physicist at the U.S. Department of Energy’s Superconducting Super Collider Laboratory in Dallas. In 1994, he became a senior physicist at the National Superconducting Cyclotron Laboratory at Michigan State University. In 2005, Grimm founded Niowave, Inc., focusing on commercializing superconducting electron linear accelerators. Under his leadership, Niowave became a global frontrunner in superconducting accelerator research. Grimm's pioneering work earned Niowave recognition as the second U.S. vendor for accelerating cavities for the International Linear Collider in 2008. The following year, Niowave became the world’s first private company to design, fabricate and test a superconducting electron injector. In 2019, Grimm received a $15 million federal grant to support Niowave's production of a key medical radioisotope for treating heart disease and cancer, and Niowave is actively involved in cancer clinical trials. Purdue honored Grimm with a Distinguished Engineering Alumnus Award in 2019.